man-user-icon Client Login Portal
    • addthis
    • link : Client Login
    • knowledge network
    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Knowledge Network
    • Contact Us
    Labaton Sucharow
    • addthis
    • link : Client Login
    • knowledge network
    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Knowledge Network
    • Contact Us
    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Contact Us
    • Knowledge Network
    • Client Login
    • Search
    • addthis
    • link : Client Login
    • knowledge network
    Labaton Sucharow
    • Ongoing Cases
    • Settled | Resolved Cases
    • Featured Cases
      • Securities
      • Derivative
      • Mergers & Acquisitions
      • REITs and Limited Partnerships
      • Consumer Products & Data Privacy

    In re HealthSouth Securities Litigation

    Settled: July 26, 2010

    As co-lead counsel, we secured $671 million in total settlements, including one of the largest settlements with an auditor in securities class action history.

    Labaton Sucharow served as co-lead counsel in In re HealthSouth Corporation Securities Litigation, a case stemming from the largest fraud ever perpetrated in the healthcare industry. On behalf of the New Mexico State Investment Council and the Educational Retirement Board of New Mexico, the Firm, along with co-counsel, filed a class action suit under federal securities laws alleging that HealthSouth falsified its revenues and funded a series of massive corporate acquisitions for the purpose of perpetrating a systematic Medicare and accounting fraud. The complaint asserts that while company executives misled investors into buying the company's stock, they sold vast amounts of their own personal shares of HealthSouth stock for huge profits. The plaintiffs also allege that HealthSouth was able to keep its fraudulent practices hidden from the public through the assistance of its auditors, Ernst & Young, and its principal banker, UBS, among others. The lead plaintiffs alleged that Ernst & Young accepted millions of dollars in purported auditing and consulting fees in exchange for turning a blind eye to the Company's accounting fraud. Similarly, the plaintiffs alleged that UBS profited from its role in concealing HealthSouth's fraud through orchestrating deceptive financial transactions, withholding information about the true financial condition of the company, and making false statements about HealthSouth's financial condition, including the publication of false analyst reports aimed at deceiving investors into believing that HealthSouth was a healthy and legitimate company. All the while, the lead plaintiffs alleged, Ernst & Young and UBS were fully aware, and indeed an integral part, of the historic fraud perpetrated on HealthSouth's stock holders. Evidence presented in connection with the guilty pleas and criminal convictions of 15 former company employees has buttressed the lead plaintiffs' prosecution of this case. 

    In early 2006, the lead plaintiffs negotiated a settlement valued at $445 million with HealthSouth Corporation and several of the company's former officers and directors, which was approved by the Court on January 11, 2007. The HealthSouth partial settlement, comprised of cash and HealthSouth securities, is one of the largest in history. On June 12, 2009, the court also granted final approval to a $109 million settlement with defendant Ernst & Young LLP, which at the time was believed to be the eighth largest securities fraud class action settlement with an auditor. On July 26, 2010, the court approved a $117 million settlement with the remaining principal defendants in the case, UBS AG, UBS Warburg LLC, Howard Capek, Benjamin Lorello and William McGahan (the UBS defendants). The settlements are being distributed to Authorized Claimants.

    The total value of the settlements for Healthsouth stockholders and Healthsouth bondholders, who were represented by separate counsel, is $804.5 million, which is the eleventh largest settlement filed after the passage of the PSLRA based on the SCAS 100 for the first quarter of 2010.

    case_study_callout_healthsouth_1

    Case Materials

    Partial Final Judgment and Order of Dismissal with Prejudice as to UBS Defendants

    Notice of Proposed Settlement of Class Action with UBS Defendants

    Order Preliminarily Approving Settlement with UBS Defendants and Providing for Notice

    UBS Proof of Claim and Release Form

    Stipulation of Settlement with UBS Defendants

    Ernst & Young LLP Proof of Claim Instructions and Form

    Stipulation of Settlement with Ernst & Young LLP

    Notice of Proposed Settlement of Class Action with Ernst & Young LLP

    Stipulation of Partial Settlement

    Preliminarily Approving Partial Settlement

    Notice of Pendency and Proposed Partial Settlement of Class Action

    Useful Links

    • Practice Areas
    • Cases
    • About Us
    • News & Events
    • Our People
    • Knowledge Center

    Our Locations

    footer-list-map_icon New York
    140 Broadway
    New York, NY 10005
    212-907-0700

    footer-list-map_icon Delaware
    222 Delaware Avenue, Suite 1510
    Wilmington, DE 19801
    302-573-2540

    Useful Links

    footer-list-map_icon Washington, D.C.
    1050 Connecticut Avenue, NW, Suite 500
    Washington, D.C. 20036
    212-907-0700

    Stay Connected

    • Facebook
    • Twitter
    • LinkedIn
    Labaton Sucharow
    • Attorney Advertising Disclaimer
    • Privacy Policy
    • Transparency in Coverage Rule
    • labaton.com
    • Labaton Sucharow All Rights Reserved 2022

    Attorney Advertising Disclaimer

    The materials appearing on this website are provided for informational purposes only and do not constitute legal advice. You should not take action based upon this information without consulting legal counsel. This site is not intended to create an attorney-client relationship. The hiring of a lawyer is an important decision that should not be based solely upon any single source of information, including advertising on this website. You may ask us to send you further information about us, and we urge you to review other sources of information about us.